| Name | (2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine |
|---|---|
| Synonyms |
1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
Sofosbuvir Intermediates 2 chloro-b-L-abinofuranosyl)-thymine biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-cboxylic Acid-d5 β-D-2'-deoxy-2'-α-F-2'-β-C-methyluridine fluoroguanosine C-methyluridine fluoro-b-D-abinofuranosyl)adenine fluoro-b-L-abinofuranosyl)-uracil deoxy-7-iodoadenosine biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-cboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine (Sofo C1) 2'-Deoxy-2'-fluoro-2'-methyluridine GS-331007 fluoro-b-D-abinofuranosyl)-5-ethyluracil Ro-2433 PSI-6206; RO-2433; PSI6206; RO2433 Uridine, 2'-deoxy-2'-fluoro-2'-Methyl-, (2'R) 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione RO fluoro-beta-d-abinofuranosyl)-5-ethyluracil deoxy-6-methoxyguanosine 5. (2'R)-2'-Deoxy-2'-fluoro-2'-Methyluridine (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine fluoro-b-D-ribofuranosyl)-isoguanine 2'-deoxy-2'-fluoro-2'-methyluridine 1-[(2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-2-yl]pyrimidine-2,4-dione 2'-Deoxy-2-floro-2'Methyl-uridine fluoro-b-D-abinofuranosyl)cytosine 1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione Uridine, 2'-deoxy-2'-fluoro-2'-Methyl-, (2'R)- PSI6206 O-4-C-Methylene-b-D-ribofuranosyl)thymine 1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione 2'-deoxy-2'-fluoro-2'-C-methyluridine deoxy-7-iodoguanosine fluoro-b-D-abinofuranosyl)guanine 2'-deoxy-2'-fluoro-2'-C-Methyluridine (N-1) 2'-Deoxy-2'-F-2'-C-methyluridine URI002 PSI 6206 int PSI6206 fluoro-b-D-abinofuranosyl)purine biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-cboxylic Acid biphenyl-4-yl)methyl]-2-ethoxy-d-benzimidazolecboxylic Acid Methyl Ester Sofosbuvir INT 1 Sofosbuvir imp-11 biphenyl-4-yl)methyl]-2-ethoxy-7-benzimidazolecboxylic Acid Methyl Ester Sofosbuvir Intermediate 4 2'-deoxy-2'-fluoro-2'-C-methyl-uridine O-trityl-b-L-abinofuranosyl)-uracil C-ethynyladenosine fluoro-b-D-abinofuranosyl)hypoxantine deoxy-O6-methylguanosine fluoro-b-D-abinofuranosyl)cytosine HCl Sofosbuvir int. N-1 fluoro-b-D-ribofuranosyl)purine fluoro-b-D-abinofuranosyl)-N2-isobutyrylguanine Sofosbuvir Nucleoside Derivative (GS-331007) (2'R)-2'-deoxy-2'-fluoro-2'-C-methyluridine fluoro-b-D-ribofuranosyl)-2-fluoroadenine |
| Description | PSI-6206 is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM. |
|---|---|
| Related Catalog | |
| Target |
EC90:>100 μM (HCV replicon)[1] |
| In Vitro | PSI-6206 (RO2433) is tested for anti-HCV activity in both a cell-based quantitative real-time RT-PCR assay and surrogate bovine viral diarrhea virus (BVDV) assays. PSI-6206 demonstrates no activity or cytoxicity in any assay[1]. The formation of the 5′-triphosphate (TP) of PSI-6130 (PSI-6130-TP) and RO2433 (RO2433-TP) increases with time and reached steady state levels at 48 h. RO2433-TP also inhibits RNA synthesis by the native HCV replicase isolated from HCV replicon cells and the recombinant HCV polymerase NS5B[2]. PSI-6206 (RO2433) is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase[3]. |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Melting Point | 237-238℃ |
| Molecular Formula | C10H13FN2O5 |
| Molecular Weight | 260.219 |
| Exact Mass | 260.080841 |
| PSA | 104.55000 |
| LogP | -0.77 |
| Index of Refraction | 1.596 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934999090 |
|
~%
863329-66-2 |
| Literature: Journal of Medicinal Chemistry, , vol. 48, # 17 p. 5504 - 5508 |
| Precursor 1 | |
|---|---|
| DownStream 2 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |